Register for our S/EIS Fund

the o2h kickstarter competition 3.0 exclusively for Israel biotech startups

give your startup a boost of chemistry…

Last date to apply - 10th May 2023

about o2h kickstarter

The o2h kickstarter competition has been designed to provide a boost to small molecule focused biotechnology companies which have raised some initial funding and need to supercharge their chemistry efforts to meet their next funding milestone. Winners will be able to give their projects a chemistry boost to accelerate to support hitting key project milestones.

o2h discovery has collaborated with several early stage biotech companies from Israel over the last 20 years. The start-up culture is one of the most vibrant in the world with scientists having an entrepreneurial drive coupled with the ambition to work on the most cutting edge biology. The start-up ecosystem is the envy of the world with many of the largest pharmaceutical companies in the world targeting Israeli companies to invest into and support through accelerators. o2h discovery has recognised this and thus we are launching the third addition of our kickstarter competition targeted at startup small molecule biotech companies in Israel.




Dedicated team of six FTE synthetic chemists of which two are fully trained and four are trainees.



Six synthetic chemists at the standard cost of one FTE.



Access to a large inventory of chemicals and reagents for synthesis.



The programme would be offered up to six months.


The competition is for pre-seed stage small molecule focused biotech companies based out of Israel which have secured initial funding from recognized grant bodies or venture/angel investors, has exciting drug target and ability to scale.


The applications will be evaluated by the o2h Kickstarter committee and 3 winners will be announced by 5th June 2023. This is a time bound competition. If supportive to the global biotech ecosystem we will run this again.

evaluation committee

Sunil Shah

Business Analysis

CEO, o2h ventures and Co-founder, o2h group

Gayathri Sadasivam

Scientific Analysis, Biology

Head of Biology, o2h discovery

Andy Morley

Scientific Analysis, Drug Discovery

Chief Scientific Officer, o2h discovery

Hemal Soni

Scientific Analysis, Chemistry Synthesis

Head of Chemistry, o2h discovery

our australian collaborators

Speak to member of our team